Comparison of Markers of Appetite and Inflammation Between Hemodialysis Patients With and Without Failed Renal Transplants

Journal of Renal Nutrition

Volumn 22, Issue 2, 2012, Pages 258-267

  Caliskan, Yasar ^a   Yelken, Berna ^a   Gorgulu, Numan ^a   Ozkok, Abdullah ^a   Yazici, Halil ^a   Telci, Aysegul ^a   Turkmen, Aydin ^a   Yildiz, Alaattin ^a   Sever, Mehmet S ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; GHRELIN; INTERLEUKIN 6; LEPTIN; SOMATOMEDIN C; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ALLOTRANSPLANTATION; APPETITE; ARTICLE; BLOOD; CHRONIC KIDNEY FAILURE; COMPARATIVE STUDY; FEMALE; HUMAN; INFLAMMATION; KIDNEY TRANSPLANTATION; MALE; MALNUTRITION; METABOLISM; METHODOLOGY; MIDDLE AGED; NUTRITIONAL STATUS; PATHOPHYSIOLOGY; RENAL REPLACEMENT THERAPY; TREATMENT FAILURE;

ADULT; APPETITE; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; FEMALE; GHRELIN; HUMANS; INFLAMMATION; INSULIN-LIKE GROWTH FACTOR I; INTERLEUKIN-6; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; LEPTIN; MALE; MALNUTRITION; MIDDLE AGED; NUTRITIONAL STATUS; RENAL DIALYSIS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT FAILURE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84857366324     PISSN: 10512276     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jrn.2011.07.005     Document Type: Article

References (58)

1. Langone A.J., Chuang P. The management of the failed renal allograft: an enigma with potential consequences. Semin Dial 2005, 18:185-187.
2. Kaplan B., Meier-Kriesche H.U. Death after graft loss: an important late study endpoint in kidney transplantation. Am J Transplant 2002, 2:970-974.
3. Ojo A., Wolfe R.A., Agodoa L.Y., et al. Prognosis after primary renal transplant failure and the beneficial effects of repeat transplantation: multivariate analyses from the United States Renal Data System. Transplantation 1998, 66:1651-1659.
4. Pecoits-Filho R., Sylvestre L.C., Stenvinkel P. Chronic kidney disease and inflammation in pediatric patients: from bench to playground. Pediatr Nephrol 2005, 20:714-720.
5. Kalantar-Zadeh K., Stenvinkel P., Pillon L., Kopple J.D. Inflammation and nutrition in renal insufficiency. Adv Ren Replace Ther 2003, 10:155-169.
6. Acchiardo S.E., Moore L.W., Latour P.A. Malnutrition as the main factor in morbidity and mortality of hemodialysis patients. Kidney Int 1983, 24:199-203.
7. Parker T.F., Laird N.M., Lowrie E.G. Comparison of the study groups in the national cooperative dialysis study and a descriptive of morbidity, and patient withdrawal. Kidney Int 1983, 23:42-49.
8. Owen W.F., Lew N.L., Liu Y., Lowrie E.G., Lazarus J.M. The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis. N Engl J Med 1993, 329:1001-1006.
9. Lowrie E.G., Lew N.L. Death risk in hemodialysis patients: the predictive value of commonly measured variables and an evaluation of death rate differences between facilities. Am J Kidney Dis 1990, 15:458-482.
10. Kopple J.D. Effect of nutrition on morbidity and mortality in maintenance dialysis patients. Am J Kidney Dis 1994, 24:1002-1009.
11. Kalantar-Zadeh K., Block G., McAllister C., Humphreys M., Kopple J. Appetite and inflammation, nutrition, anemia, and clinical outcome in hemodialysis patients. Am J Clin Nutr 2004, 80:299-307.
12. Burrowes J., Larive B., Chertow G., et al. Self-reported appetite, hospitalization and death in hemodialysis patients: findings from the Hemodialysis (HEMO) study. Nephrol Dial Transplant 2005, 20:2765-2774.
13. Kojima M., Kangawa K. Ghrelin: structure and function. Physiol Rev 2005, 85:495-522.
14. Friedman J.M., Halaas J.L. Leptin and the regulation of body weight in mammals. Nature 1998, 395:763-770.
15. Nakazato M., Murakami N., Date Y., et al. A role for ghrelin in the central regulation of feeding. Nature 2001, 409:194-198.
16. Kojima M., Hosoda H., Date Y., Nakazato M., Matsuo H., Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999, 402:656-660.
17. Yoshimoto A., Mori K., Sugawara A., et al. Plasma ghrelin and desacyl ghrelin concentrations in renal failure. J Am Soc Nephrol 2002, 13:2748-2752.
18. Guebre-Egziabher F., Bernhard J., Geelen G., Malvoisin E., Hadj-Aissa A., Fouque D. Leptin, adiponectin, and ghrelin dysregulation in chronic kidney disease. J Renal Nutr 2005, 15:116-120.
19. Tentolouris N., Makrilakis K., Doulgerakis D., et al. Increased plasma ghrelin levels in chronic renal failure are not associated with hemodynamic parameters. Horm Metab Res 2005, 37:646-652.
20. Chang C.C., Hung C.H., Yen C.S., Hwang K.L., Lin C.Y. The relationship of plasma ghrelin level to energy regulation, feeding and left ventricular function in nondiabetic hemodialysis patients. Nephrol Dial Transplant 2005, 20:2172-2177.
21. Cheung W.W., Paik K.H., Mak R.H. Inflammation and cachexia in chronic kidney disease. Pediatr Nephrol 2010, 25:711-724.
22. Ayala E.R., Pecoits-Filho R., Heimburger O., et al. Association between plasma ghrelin levels and body composition in end-stage renal disease: a longitudinal study. Nephrol Dial Transplant 2004, 19:421-426.
23. Stenvinkel P., Heimburger O., Paultre F., et al. Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int 1999, 55:1899-1911.
24. Yeun J.Y., Kaysen G.A. Factors influencing serum albumin in dialysis patients. Am J Kidney Dis 1998, 32:118-125.
25. Stenvinkel P., Barany P., Chung S.H., Lindholm B., Heimburger O. A comparative analysis of nutritional parameters as predictors of outcome in male and female ESRD patients. Nephrol Dial Transplant 2002, 17:1266-1274.
26. Kaizu Y., Kimura M., Yoneyama T., Miyaji K., Hibi I., Kumagai H. Interleukin-6 may mediate malnutrition in chronic hemodialysis patients. Am J Kidney Dis 1998, 31:93-100.
27. Bergstrom J. Regulation of appetite in chronic renal failure. Miner Electrolyte Metab 1999, 25:291-297.
28. Roubicek T., Bartlova M., Krajickova J., et al. Increased production of proinflammatory cytokines in adipose tissue of patients with end-stage renal disease. Nutrition 2009, 25:762-768.
29. Flores E.A., Bistrian B.R., Pomposelli J.J., Dinarello C.A., Blackburn G.L., Istfan N.W. Infusion of tumor necrosis factor/catechin promotes muscle catabolism in the rat: a synergistic effect with interleukin 1. J Clin Invest 1989, 83:1614-1622.
30. Espat N.J., Copeland E.M., Moldawr L.L. Tumor necrosis factor and cachexia: a current perspective. Surg Oncol 1994, 3:255-262.
31. McCarthy D.O. Tumor necrosis factor alpha and interleukin-6 have differential effects on food intake and gastric emptying in fasted rats. Res Nurs Health 2000, 23:222-228.
32. Streetz K.L., Wüstefeld T., Klein C., Manns M.P., Trautwein C. Mediators of inflammation and acute phase response in the liver. Cell Mol Biol 2001, 47:661-673.
33. Suffredini A.F., Fantuzzi G., Badolato R., Oppenheim J.J., O'Grady N.P. New insights into the biology of the acute phase response. J Clin Immunol 1999, 19:203-214.
34. Lin-Tan D.T., Lin J.L., Wang L.H., et al. Fasting glucose levels in predicting 1-year all-cause mortality in patients who do not have diabetes and are on maintenance hemodialysis. J Am Soc Nephrol 2007, 18:2385-2391.
35. Noori N., Kopple J.D. Effect of diabetes mellitus on protein-energy wasting and protein wasting in end-stage renal disease. Semin Dial 2010, 23:178-184.
36. Burrowes J., Larive B., Cockram D.B., et al. Effects of dietary intake, appetite, and eating habits on dialysis and non-dialysis treatment days in hemodialysis patients: cross-sectional results from the HEMO study. J Ren Nutr 2003, 13:191-198.
37. Burrowes J.D., Powers S.N., Cockram D.B., et al. Use of an appetite and diet assessment tool in the pilot phase of a hemodialysis clinical trial: mortality and morbidity in hemodialysis study. J Ren Nutr 1996, 6:229-232.
38. USRDS 2009 Annual Report 2009, U.S. Renal Data System, National Institute of Health, National Institute of Diabetes and Digestive and Kidney Disease, Bethesda, MD.
39. Suleymanlar G., Seyahi N., Altiparmak M.R., Serdengeçti K. Current status of renal replacement therapy in Turkey: a summary of Turkish society of nephrology 2009 annual registry report. Turk Nephrol Dial Transplant 2011, 20:1-6.
40. Stenvinkel P., Lindholm B., Heimburger O. Novel approaches in an integrated therapy of inflammatory-associated wasting in end-stage renal disease. Semin Dial 2004, 17:505-515.
41. Yelken B.M., Gorgulu N., Caliskan Y., et al. Comparison of nutritional status in hemodialysis patients with and without failed renal allografts. Clin Transplant 2010, 24:481-487.
42. López-Gómez J.M., Pérez-Flores I., Jofré R., et al. Presence of a failed kidney transplant in patients who are on hemodialysis is associated with chronic inflammatory state and erythropoietin resistance. J Am Soc Nephrol 2004, 15:2494-2501.
43. Ayus J.C., Achinger S.G., Lee S., Sayegh M.H., Go A.S. Transplant nephrectomy improves survival following a failed renal allograft. J Am Soc Nephrol 2010, 21:374-380.
44. Stenvinkel P., Barany P., Heimburger O., Pecoits-Filho R., Lindholm B. Mortality, malnutrition, and atherosclerosis in ESRD: what is the role of interleukin-6?. Kidney Int 2002, 61:103-108.
45. Kaysen G.A., Dubin J.A., Muller H.G., Rosales L.M., Levin N.M. The acute-phase response varies with time and predicts serum levels in hemodialysis patients. Kidney Int 2000, 58:346-352. The HEMO Study Group.
46. Fouque D., Kalantar-Zadeh K., Kopple J., et al. A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease. Kidney Int 2008, 73:391-398.
47. Heimbürger O., Lönnqvist F., Danielsson A., Nordenström J., Stenvinkel P. Serum immunoreactive leptin concentration and its relation to the body fat content in chronic renal failure. J Am Soc Nephrol 1997, 8:1423-1430.
48. Young G.A., Woodrow G., Kendall S., et al. Increased plasma leptin/fat ratio in patients with chronic renal failure: a cause of malnutrition?. Nephrol Dial Transplant 1997, 12:2318-2323.
49. Vaziri N.D. Oxidative stress in chronic renal failure: the nature, mechanism and consequences. Semin Nephrol 2004, 24:469-473.
50. Van der Lely A.J., Tschöp M., Heiman M.L., Ghigo E. Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin. Endocr Rev 2004, 25:426-457.
51. Muccioli G., Tschöp M., Papotti M., Deghenghi R., Heiman M., Ghigo E. Neuroendocrine and peripheral activities of ghrelin: implications in metabolism and obesity. Eur J Pharmacol 2002, 440:235-254.
52. Arbeiter A.K., Büscher R., Petersenn S., Mann K., Hoyer P.F. Ghrelin and other appetite-regulating hormones in pediatric patients with chronic renal failure during dialysis and following kidney transplantation. Nephrol Dial Transplant 2009, 24:643-646.
53. Mafra D., Jolivot A., Chauveau P., et al. Are ghrelin and leptin involved in food intake and body mass index in maintenance hemodialysis?. J Ren Nutr 2010, 20:151-157.
54. Date Y., Nakazato M., Hashiguchi S., et al. Ghrelin is present in pancreatic alpha-cells of humans and rats and stimulates insulin secretion. Diabetes 2002, 51:124-129.
55. Kirchgessner T.G., Uysal K.T., Wiesbrock S.M., et al. Tumor necrosis factor-alpha contributes to obesity-related hyperleptinemia by regulating leptin release from adipocytes. J Clin Invest 1997, 100:2777-2782.
56. Aminzadeh M.A., Pahl M.V., Barton C.H., Doctor N.S., Vaziri N.D. Human uraemic plasma stimulates release of leptin and uptake of tumour necrosis factor-alpha in visceral adipocytes. Nephrol Dial Transplant 2009, 24:3626-3631.
57. Arvat E., Di Vito L., Broglio F., et al. Preliminary evidence that ghrelin, the natural GH secretagogue (GHS)-receptor ligand, strongly stimulates GH secretion in humans. J Endocrinol Invest 2000, 23:493-495.
58. Pöykkö S.M., Ukkola O., Kauma H., Kellokoski E., Hörkkö S., Kesäniemi Y.A. The negative association between plasma ghrelin and IGF-I is modified by obesity, insulin resistance and type 2 diabetes. Diabetologia 2005, 48:309-316.